These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
781 related articles for article (PubMed ID: 34262565)
1. The Immune Subtypes and Landscape of Gastric Cancer and to Predict Based on the Whole-Slide Images Using Deep Learning. Chen Y; Sun Z; Chen W; Liu C; Chai R; Ding J; Liu W; Feng X; Zhou J; Shen X; Huang S; Xu Z Front Immunol; 2021; 12():685992. PubMed ID: 34262565 [TBL] [Abstract][Full Text] [Related]
2. The Immune Subtypes and Landscape of Squamous Cell Carcinoma. Li B; Cui Y; Nambiar DK; Sunwoo JB; Li R Clin Cancer Res; 2019 Jun; 25(12):3528-3537. PubMed ID: 30833271 [TBL] [Abstract][Full Text] [Related]
3. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer. Yang KS; Xu CQ; Lv J Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442 [TBL] [Abstract][Full Text] [Related]
4. Development and verification of a manganese metabolism- and immune-related genes signature for prediction of prognosis and immune landscape in gastric cancer. Han X; Leng C; Zhao S; Wang S; Chen S; Wang S; Zhang M; Li X; Lu Y; Wang B; Qi W Front Immunol; 2024; 15():1377472. PubMed ID: 38807601 [TBL] [Abstract][Full Text] [Related]
5. A Signature-Based Classification of Gastric Cancer That Stratifies Tumor Immunity and Predicts Responses to PD-1 Inhibitors. Li S; Gao J; Xu Q; Zhang X; Huang M; Dai X; Huang K; Liu L Front Immunol; 2021; 12():693314. PubMed ID: 34177954 [TBL] [Abstract][Full Text] [Related]
6. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates. Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193 [TBL] [Abstract][Full Text] [Related]
7. Cytolytic activity score as a biomarker for antitumor immunity and clinical outcome in patients with gastric cancer. Hu Q; Nonaka K; Wakiyama H; Miyashita Y; Fujimoto Y; Jogo T; Hokonohara K; Nakanishi R; Hisamatsu Y; Ando K; Kimura Y; Masuda T; Oki E; Mimori K; Oda Y; Mori M Cancer Med; 2021 May; 10(9):3129-3138. PubMed ID: 33769705 [TBL] [Abstract][Full Text] [Related]
8. Identification of immunotherapy-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognostic signature in gastric carcinoma. Li J; Han T; Yang J; Wang X; Wang Y; Yang R; Yang Q Aging (Albany NY); 2024 Jun; 16(14):11185-11207. PubMed ID: 39074262 [TBL] [Abstract][Full Text] [Related]
9. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy. Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of a 14 immune-related gene pair signature to predict the prognosis and immune features of gastric cancer. Liu C; Chen B; Huang Z; Hu C; Jiang L; Zhao C Int Immunopharmacol; 2020 Dec; 89(Pt B):107074. PubMed ID: 33049494 [TBL] [Abstract][Full Text] [Related]
11. Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature. Zhang S; Lv M; Cheng Y; Wang S; Li C; Qu X BMC Cancer; 2021 Dec; 21(1):1324. PubMed ID: 34893046 [TBL] [Abstract][Full Text] [Related]
12. Glycolysis-related genes predict prognosis and indicate immune microenvironment features in gastric cancer. Xu L; Liu J; An Y; Zhou L; Sun H; Xu Z; Wang D; Liang Z; Xu C; Wang B; Li W BMC Cancer; 2024 Aug; 24(1):979. PubMed ID: 39118022 [TBL] [Abstract][Full Text] [Related]
13. Genomic analysis and clinical implications of immune cell infiltration in gastric cancer. Wu M; Wang Y; Liu H; Song J; Ding J Biosci Rep; 2020 May; 40(5):. PubMed ID: 32338286 [TBL] [Abstract][Full Text] [Related]
14. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study. Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041 [TBL] [Abstract][Full Text] [Related]
15. The cancer-associated fibroblast-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer. Mak TK; Li X; Huang H; Wu K; Huang Z; He Y; Zhang C Front Immunol; 2022; 13():951214. PubMed ID: 35967313 [TBL] [Abstract][Full Text] [Related]
16. m Zhang B; Wu Q; Li B; Wang D; Wang L; Zhou YL Mol Cancer; 2020 Mar; 19(1):53. PubMed ID: 32164750 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive multi-omics analysis of pyroptosis for optimizing neoadjuvant immunotherapy in patients with gastric cancer. Wang JB; Gao YX; Ye YH; Zheng QL; Luo HY; Wang SH; Zhang T; Jin QW; Zheng CH; Li P; Lin JX; Chen QY; Cao LL; Yang YH; Huang CM; Xie JW Theranostics; 2024; 14(7):2915-2933. PubMed ID: 38773976 [No Abstract] [Full Text] [Related]
18. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature. Zhang C; Li D; Yu R; Li C; Song Y; Chen X; Fan Y; Liu Y; Qu X Front Immunol; 2021; 12():651033. PubMed ID: 34054812 [TBL] [Abstract][Full Text] [Related]
19. PANoptosis subtypes predict prognosis and immune efficacy in gastric cancer. Liu Z; Sun L; Peng X; Zhu J; Wu C; Zhu W; Huang C; Zhu Z Apoptosis; 2024 Jun; 29(5-6):799-815. PubMed ID: 38347337 [TBL] [Abstract][Full Text] [Related]
20. The DNA damage repair-related lncRNAs signature predicts the prognosis and immunotherapy response in gastric cancer. Zhao Z; Mak TK; Shi Y; Huang H; Huo M; Zhang C Front Immunol; 2023; 14():1117255. PubMed ID: 37457685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]